Tianhai Lin

1.3k total citations
62 papers, 704 citations indexed

About

Tianhai Lin is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tianhai Lin has authored 62 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Surgery, 21 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tianhai Lin's work include Bladder and Urothelial Cancer Treatments (33 papers), Urinary and Genital Oncology Studies (19 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). Tianhai Lin is often cited by papers focused on Bladder and Urothelial Cancer Treatments (33 papers), Urinary and Genital Oncology Studies (19 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). Tianhai Lin collaborates with scholars based in China, United States and Switzerland. Tianhai Lin's co-authors include Qiang Wei, Lu Yang, Jianzhong Ai, Ping Tan, Hang Xu, Liangren Liu, Shi Qiu, Xiang Tu, Yin Huang and Kun Jin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Tianhai Lin

57 papers receiving 701 citations

Peers

Countries citing papers authored by Tianhai Lin

Since Specialization

Citations

This map shows the geographic impact of Tianhai Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianhai Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianhai Lin more than expected).

Fields of papers citing papers by Tianhai Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianhai Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianhai Lin. The network helps show where Tianhai Lin may publish in the future.

Co-authorship network of co-authors of Tianhai Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Tianhai Lin. A scholar is included among the top collaborators of Tianhai Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianhai Lin. Tianhai Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Moving to wheat‐farming regions increases analytic thought, but moving to cities does not: A three‐wave longitudinal study 2025 ·British Journal of Psychology ·Alexander Scott English, Thomas Talhelm, (unknown), Liuqing Wei, (unknown), Jianhong Ma, Haitao Yu, (unknown), (unknown), Tianhai Lin, Meng Zhang, Lijuan Hu, Peng Cui, (unknown), (unknown), (unknown), Zhijia Zeng, (unknown), (unknown)	0
2	Chemical Affinity Capture of Plasma Extracellular Vesicles Enables Efficient and Large-Scale Proteomic Identification of Prostate Cancer Biomarkers 2025 ·ACS Nano ·Wenjuan Zeng, Yong Zhang, (unknown), Shisheng Wang, Tianhai Lin, Tao Su, (unknown), Yujia Yuan, (unknown), Yi Zhong, Li Li, Dingkun Zhang, Meng Gong, Jingqiu Cheng, Jingping Liu, Shan Liu, Weiya Wang, (unknown), Hao Yang	4
3	Bladder sparing by short-course radiotherapy combined with toripalimab in high-risk/extremely high-risk non-muscle invasive bladder cancer (HOPE-04): study protocol for a single-arm, prospective, phase II trial 2024 ·BMJ Open ·Feng Wen, Tianhai Lin, Peng Zhang, Hao Zeng, Qiang Wei, Yali Shen	1
4	Preliminary results from a multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced muscle-invasive urothelial bladder cancer (Hope-03). 2024 ·Journal of Clinical Oncology ·Feng Wen, (unknown), Tianhai Lin, (unknown), Yali Shen	2
5	Preoperative low plasma creatine kinase levels predict worse survival outcomes in bladder cancer after radical cystectomy 2024 ·International Urology and Nephrology ·Yifan Li, (unknown), Tianhai Lin, Jiapeng Zhang, Jianzhong Ai, Shiyu Zhang, (unknown), Ping Tan, Peng Zhang, Qiang Wei, Xiaonan Zheng, Lu Yang	2
6	Targeting histone modifiers in bladder cancer therapy — preclinical and clinical evidence 2024 ·Nature Reviews Urology ·Shiyu Zhang, Tianhai Lin, Xingyu Xiong, Chong Chen, Ping Tan, Qiang Wei	19
7	RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2-positive locally advanced muscle-invasive urothelial bladder cancer: a multi-center phase Ib/II study (HOPE-03) 2024 ·Frontiers in Oncology ·Feng Wen, Tianhai Lin, Peng Zhang, Yali Shen	7
8	Transperineal 3-Core Magnetic Resonance Imaging Ultrasound Fusion Targeted Plus Laterally 6-Core Systematic Biopsy in Prostate Cancer Diagnosis 2024 ·Clinical Genitourinary Cancer ·Chichen Zhang, (unknown), Qiong Zhang, (unknown), (unknown), Ling Nie, Xueqin Chen, Zhenhua Liu, Tianhai Lin, (unknown), Lu Yang, Shi Qiu, Yige Bao, (unknown), Xiang Tu	1
9	Transperineal magnetic resonance imaging targeted biopsy versus transrectal route in the detection of prostate cancer: a systematic review and meta-analysis 2023 ·Prostate Cancer and Prostatic Diseases ·(unknown), Xiang Tu, (unknown), Jianjun Ye, Tianhai Lin, (unknown), Lu Yang, Shi Qiu, Yige Bao, (unknown)	20
10	A phase 2, open-label study of neoadjuvant chemotherapy plus tislelizumab followed by radiotherapy-based, bladder-preserving treatment for high risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02). 2023 ·Journal of Clinical Oncology ·(unknown), Tianhai Lin, Peng Zhang, Ping Tan, Xiaonan Zheng, Yali Shen	1
11	Comprehensive Plasma N-Glycoproteome Profiling Based on EThcD-sceHCD-MS/MS 2022 ·Frontiers in Chemistry ·Yonghong Mao, Tao Su, Tianhai Lin, Hao Yang, Yang Zhao, Yong Zhang, Xinhua Dai	12
12	SRT1720 inhibits the growth of bladder cancer in organoids and murine models through the SIRT1-HIF axis 2021 ·Oncogene ·Ping Tan, Manli Wang, (unknown), Yiyun Wang, Jiajia Du, Jian Wang, Lu Qi, (unknown), Peng Zhang, Tianhai Lin, Jiapeng Zhang, Lu Yang, Jingyao Chen, Ping Han, Qiyong Gong, Yu Liu, Chong Chen, Qiang Wei	41
13	Holmium laser technologies versus photoselective greenlight vaporization for patients with benign prostatichyperplasia: a meta-analysis 2020 ·Lasers in Medical Science ·Liao Peng, Xiaonan Zheng, (unknown), Xiao Zeng, Qing‐Yu He, Guo Chen, Tianhai Lin, Hong Shen, Deyi Luo	3
14	Use of Tregs as a cell‐based therapy via CD39 for benign prostate hyperplasia with inflammation 2020 ·Journal of Cellular and Molecular Medicine ·Xi Jin, Tianhai Lin, Guang Yang, Huawei Cai, Bo Tang, Xinyang Liao, Huifang Li, Xiaoting Chen, Lina Gong, Hang Xu, Yi Sun, Ping Tan, (unknown), (unknown), Jianzhong Ai, Kunjie Wang, Qiang Wei, Lu Yang, Hong Li	9
15	Comparative effectiveness of open, laparoscopic and robot-assisted radical cystectomy for bladder cancer: a systematic review and network meta-analysis 2020 ·Minerva Urologica e Nefrologica ·Dechao Feng, (unknown), (unknown), Tianhai Lin, Yin Tang, Ping Han	20
16	Adult primary testicular lymphoma: clinical features and survival in a series of patients treated at a high-volume institution in China 2020 ·BMC Cancer ·Bo Chen, (unknown), Li Lai, Jianbing Guo, Zeyu Chen, Yin Huang, Shi Qiu, Tianhai Lin, Yue Gou, Na Ma, Lu Yang, Liangren Liu, Qiang Wei	16
17	The optimal core number and site for MRI-targeted biopsy of prostate? A systematic review and pooled analysis 2020 ·Minerva Urologica e Nefrologica ·Xiang Tu, Tianhai Lin, (unknown), Zhenhua Liu, Lu Yang, Qiang Wei	17
18	<p>Immune-related adverse events following administration of anti-cytotoxic T-lymphocyte-associated protein-4 drugs: a comprehensive systematic review and meta-analysis</p> 2019 ·Drug Design Development and Therapy ·Hang Xu, Ping Tan, Xiaonan Zheng, Yu Huang, Tianhai Lin, Qiang Wei, Jianzhong Ai, Lu Yang	25
19	Validation of the preoperative controlling nutritional status score as an independent predictor in a large Chinese cohort of patients with upper tract urothelial carcinoma 2018 ·Cancer Medicine ·Hang Xu, Ping Tan, Xi Jin, Jianzhong Ai, Tianhai Lin, (unknown), Lu Yang, Qiang Wei	17
20	Metabolic syndrome and upper tract urothelial carcinoma: A retrospective analysis from a large Chinese cohort 2018 ·Urologic Oncology Seminars and Original Investigations ·Hang Xu, Ping Tan, Xiaonan Zheng, Jianzhong Ai, Tianhai Lin, Xi Jin, Lina Gong, (unknown), Lu Yang, Qiang Wei	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact